February 21, 2017
Gaithersburg’s NexImmune acquired by investor consortium of Teva Pharmaceuticals , Celgene Corp. , Medtronic alums – Washington Business Journal
Gaithersburg-based NexImmune, a biotech developing immunotherapy treatments for cancer, has been acquired by a consortium…
